You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 16, September 12, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis

Felix Stickel, MD; Christoph H. Österreicher, MD; Christian Datz, MD; Peter Ferenci, MD; Marco Wölfel, BS; Wolfgang Norgauer, MD; Michael R. Kraus, MD, DSc; Fritz Wrba, MD; Claus Hellerbrand, MD; Detlef Schuppan, MD, PhD

Arch Intern Med. 2005;165:1835-1840.

Background  Oxidative stress plays an important pathogenic role in hereditary hemochromatosis (HHC) and chronic hepatitis C virus infection (CHC). Several enzymes involved in the degradation of reactive oxidants and xenobiotics, such as glutathione S-transferase P1 (GSTP1) and manganese superoxide dismutase (MnSOD), reveal polymorphisms that affect their antioxidant capacity and may therefore modulate the progression to cirrhosis. Our objective was to establish the role of the functional polymorphisms of GSTP1 (codon 105 Ile->Val) and MnSOD (codon 16 of precursor protein Ala->Val) on the evolution of cirrhosis in patients with HHC and CHC.

Methods  One hundred seventy-two patients with HHC who were homozygous for the C282Y mutation and 285 patients with CHC underwent liver biopsy and genotyping for the GSTP1 and MnSOD polymorphisms.

Results  In HHC, the GSTP1 Val/Val genotype was more common in patients with than in those without cirrhosis (14.8% vs 2.1%, P = .009), whereas the distribution of MnSOD variants was not different. Logistic regression analysis identified GSTP1 Val/Val genotype, serum ferritin level, male sex, and age as independent predictors for the presence of cirrhosis. The odds ratio for the GSTP1 Val/Val genotype for the development of cirrhosis was 3.85 (95% confidence interval, 1.18-12.62; P = .03). However, in patients with CHC, the GSTP1 and MnSOD genotypes were not associated with cirrhosis.

Conclusions  Cirrhosis is more likely to develop in C282Y homozygotes with the GSTP1 Val/Val genotype than in those with non-Val/Val genotypes, which in part explains the variable phenotypic expression of HHC and highlights the central role of oxidative stress in its pathogenesis.


Author Affiliations: Department of Medicine I, University of Erlangen-Nürnberg, Erlangen, Germany (Drs Stickel and Schuppan and Mr Wölfel); Departments of Medicine IV (Drs Österreicher and Ferenci) and Clinical Pathology (Dr Wrba), University of Vienna, Vienna, Austria; Department of Medicine, Oberndorf Hospital, Salzburg, Austria (Dr Datz); Department of Medicine, Theresien Medical Center, Nürnberg, Germany (Dr Norgauer); Department of Medicine, University of Würzburg, Würzburg, Germany (Dr Kraus); and Department of Medicine I, University of Regensburg, Regensburg, Germany (Dr Hellerbrand).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Practicing Medicine at the Front Lines of the Genomic Revolution
Wendy S. Rubinstein and Hemant K. Roy
Arch Intern Med. 2005;165(16):1815-1817.
EXTRACT | FULL TEXT  

Genetic Liability to Fractures in the Elderly
Karl Michaëlsson, Håkan Melhus, Helene Ferm, Anders Ahlbom, and Nancy L. Pedersen
Arch Intern Med. 2005;165(16):1825-1830.
ABSTRACT | FULL TEXT  

Ready for Genomic Medicine? Perspectives of Health Care Decision Makers
Paul R. Billings, Rick J. Carlson, Josh Carlson, Mary Cain, Charles Wilson, Peter Shorett, and Wendy Everett
Arch Intern Med. 2005;165(16):1917-1919.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sex, Drugs, and 'Heavy Metal': Does Diet Also Matter in the Clinical Expression of Hereditary Hemochromatosis?
McCune
Mayo Clin Proc. 2008;83:526-528.
FULL TEXT  

Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
Wood et al.
Blood 2008;111:4456-4462.
ABSTRACT | FULL TEXT  

Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis
Osterreicher et al.
Mutagenesis 2007;22:305-310.
ABSTRACT | FULL TEXT  

THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE
STICKEL and OSTERREICHER
Alcohol Alcohol 2006;41:209-224.
ABSTRACT | FULL TEXT  

Practicing Medicine at the Front Lines of the Genomic Revolution
Rubinstein and Roy
Arch Intern Med 2005;165:1815-1817.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.